Promotion of excisional wound repair by a menstrual blood-derived stem cell-seeded decellularized human amniotic membrane

Biomed Eng Lett. 2018 Sep 11;8(4):393-398. doi: 10.1007/s13534-018-0084-1. eCollection 2018 Nov.

Abstract

This is the first study demonstrating the efficacy of menstrual blood-derived stem cell (MenSC) transplantation via decellularized human amniotic membrane (DAM), for the promotion of skin excisional wound repair. The DAM was seeded with MenSCs at the density of 3 × 104 cells/cm2 and implanted onto a rat's 1.50 × 1.50 cm2 full-thickness excisional wound defect. The results of wound closure and histopathological examinations demonstrated that the MenSC-seeded DAM could significantly improve the wound healing compared with DAM-treatment. All in all, our data indicated that the MenSCs can be a potential source for cell-based therapies to regenerate skin injuries.

Keywords: Amniotic membrane; Menstrual blood-derived stem cells; Wound healing.